Skip to main content

Fundamentals-first equity research for GCC markets

Screener Disclosures Contact Us Privacy Policy Terms of Use

© 2026 premargin. All rights reserved.

LinkedIn X Instagram

Research updates, no noise

you@example.com Research updates, no noise

you@example.com

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

EMAAR12.10-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

ALRAJHI104.10-0.2%

MAADEN63.70-1.2%

SABIC58.40-0.9%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

ALRAJHI104.10-0.2%

MAADEN63.70-1.2%

SABIC58.40-0.9%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

Resume trading on Gulf Pharmaceutical Industries-JULPHAR shares on 13 Feb 2026 | premargin

Resume trading on Gulf Pharmaceutical Industries-JULPHAR shares on 13 Feb 2026

·ADX·Other·February 13, 2026·View on exchange

AI Summary

Trading on Gulf Pharmaceutical Industries (JULPHAR) shares resumed on February 13, 2026, following the release of preliminary results for the fiscal year ended December 31, 2025.
Net profit for the year reached AED 175.3 million, a significant increase from AED 35.0 million in 2024, supported by a one-off capital gain of AED 118.7 million.

Revenues from continuing operations grew 6.8% to AED 1,059.7 million, while EBITDA from continuing operations rose 15% to AED 101.9 million.

Earnings per share improved to AED 0.15, compared to a loss per share of AED 0.01 in the previous fiscal year.

Loading PDF preview...

Attachments

Resume trading on Gulf Pharmaceutical Industries-JULPHAR shares on 13 Feb 2026

Gulf Pharmaceutical Industries

Gulf Pharmaceutical Industries